Bullish option flow detected in TG Therapeutics with 4,912 calls trading, 4x expected, and implied vol increasing over 3 points to 54.28%. Jul-24 21 calls and 6/28 weekly 17.5 calls are the most active options, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 0.13. Earnings are expected on July 30th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TGTX:
- TG Therapeutics Shareholders Back Growth at Annual Meeting
- TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
- TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
- TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting